Pinealon vs Semax
Research Verdict
Neither compound has a universal evidence advantage. Both peptides serve distinct research goals with comparable evidence; choose by target mechanism.
Quick Answers
Which is better, Pinealon or Semax?
Neither compound has a universal evidence advantage. Both peptides serve distinct research goals with comparable evidence; choose by target mechanism.
What is the key difference between Pinealon and Semax?
Semax is an ACTH(4-7) analog with BDNF-mediated neuroprotection validated across multiple studies; pinealon is a Khavinson tripeptide with claimed neuroprotective effects that lack controlled evidence.
Evidence Comparison
Semax: multicenter RCT in ischemic stroke (Lebedeva 2008, n=60), approved in Russia and Ukraine. Pinealon: single-group studies from the Khavinson lab only, no controlled trials, no independent replication. Semax is categorically stronger.
Evidence Context Favoring Pinealon
No evidence-based scenario favors pinealon over semax for neuroprotection or cognitive enhancement.
Evidence Context Favoring Semax
Any neuroprotective or cognitive enhancement research - semax has the multicenter RCT evidence and regulatory approval.
Side-by-Side Snapshot
| Evidence grade | Pinealon: Level D Semax: Level C |
|---|---|
| Research status | Pinealon: Early Research Semax: Approved Outside US |
| Primary category | Pinealon: Cognitive & Nootropic Semax: Cognitive & Nootropic |
| Cited studies | Pinealon: 2 Semax: 2 |